View Future GrowthThis company listing is no longer activeThis company may still be operating, however this listing is no longer active. Find out why through their latest events.See Latest EventsCBD Global Sciences 과거 순이익 실적과거 기준 점검 0/6CBD Global Sciences 의 수입은 연평균 -4.3%의 비율로 감소해 온 반면, Pharmaceuticals 산업은 연평균 23.4%의 비율로 증가했습니다. 매출은 연평균 40.5%의 비율로 감소해 왔습니다.핵심 정보-4.31%순이익 성장률19.99%주당순이익(EPS) 성장률Pharmaceuticals 산업 성장률23.06%매출 성장률-40.54%자기자본이익률n/a순이익률-1,253.65%최근 순이익 업데이트31 Mar 2022최근 과거 실적 업데이트업데이트 없음모든 업데이트 보기Recent updates공시 • Apr 30Hempacco Co., Inc. (NasdaqCM:HPCO) entered into a non-binding letter of intent to acquire CBD Global Sciences Inc.Hempacco Co., Inc. (NasdaqCM:HPCO) entered into a non-binding letter of intent to acquire CBD Global Sciences Inc. on April 30, 2024. The combined company, to retain the name “Illumination Brands”. The parties have not yet finalized the terms of the potential business combination, a definitive combination agreement has not yet been entered into, and there is no guarantee that a definitive agreement will be entered into, or that the contemplated business combination will ever occur.Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Jeff Hays was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.공시 • Apr 27CBD Global Sciences Inc. Announces Change of Chief Financial OfficerCBD Global Sciences Inc. announced that Mr. Alexander McAulay tendered his resignation as Chief Financial Officer (“CFO”) of the Company effective April 14, 2022. The Company also announced that Mr. Glenn Dooley has been appointed as the interim Chief Financial Officer of the Company effective April 14, 2022. Mr. Dooley is also a director and Chief Operating Officer of the Company. He was a co-founder of Strasburg Pharms, LLC, SMBT, LLC and CannaOil Inc., all wholly-owned subsidiaries of Global NV. He is also a co-founder/co-owner, broker and operations manager of MAC5 Mortgage Inc. which he founded with Brad Wyatt in 2006.공시 • Apr 06CBD Global Sciences Inc., Annual General Meeting, May 12, 2022CBD Global Sciences Inc., Annual General Meeting, May 12, 2022.공시 • Feb 17CBD Global Sciences, Inc. Announces the Successful Launch of Rap Snacks in the Colorado Market That Exceeded First Week Sales ExpectationsCBD Global Sciences Inc. announced the successful launch of Rap Snacks in the Colorado market that exceeded first week sales expectations. Within the first week of sales to the first few hundred of over 5000 stores in the Colorado and Wyoming markets the team sold through its first order of RAP SNACKS® and has placed additional and larger orders as demand for the tasty snack grows exponentially. Within the first couple of days into its soft launch store owners gobbled up all the inventory forcing a reorder of the product to continue to introduce Colorado and parts of Wyoming to Rap Snacks. Shortly after the launch of the snack product, the Oowee Lemonade made its way into the distribution channel with the same positive response for the new products.Board Change • Sep 28No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.공시 • Mar 17Legacy Distribution Group, a Subsidiary of CBD Global Sciences, to Begin Distribution for LIFEAID Beverage Co.(R)CBD Global Sciences Inc., shared that it is adding new brands to its distribution channel. Legacy Distribution Group, "Legacy Distribution" (Denver, CO) is one of the country's first CBD-only Direct Store Delivery (DSD) distributors. CBD Global's Legacy Distribution Group is excited to announce the addition of LIFEAID Beverage Co.(R) to its family of brands. Legacy will be carrying the LIFEAID Hemp line and expects it to be one of the most successful products in their portfolio.Is New 90 Day High Low • Feb 06New 90-day high: CA$0.34The company is up 15% from its price of CA$0.30 on 06 November 2020. The Canadian market is up 14% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Pharmaceuticals industry, which is up 70% over the same period.공시 • Jan 13Ed McCaffrey and CBD Global Sciences Sign A Two-Year Endorsement Agreement with Aethics(TM)CBD Global Sciences Inc. announced the finalization of an agreement with Ed McCaffrey, three-time Superbowl Champion and Pro Bowl Athlete, to endorse the Company's CBD infused sports wellness brand Aethics(TM). Ed McCaffrey, former NFL Athlete, has decided to endorse Aethics(TM), a CBD infused sports wellness product line that includes full spectrum tinctures, topicals, hydration and confectionary products. Ed was extremely pleased to find a CBD infused product line geared towards athletes that focuses on mitigating pain and other ailments for the human body in an all-natural way.공시 • Jan 09CBD Global Sciences, Inc. Announces to Launch of the New CBD Product Line Dog Unleashed CBDCBD Global Sciences Inc. announced the launch of the new CBD product line “Dog Unleashed CBD”. Dog the Bounty Hunter and CBD Global Sciences have partnered to create a new CBD brand called ‘Dog Unleashed CBD’ which has been rolled out with a robust line of CBD products aimed at addressing multiple ailments in the human body with a holistic approach. Initial sales of Dog Unleashed CBD can be found at www.dogunleashedcbd.com, an internet sales platform. The product launch is timed to coincide with his reality TV docudrama Dog Unleashed, that is airing on a subscription-based app and will be streaming online. The initial product line will offer 12 different SKUs focused on multi-flavored tinctures offered in three different strengths 1000MG, 2000MG and 3500MG. In addition to the tincture products, Dog will offer both lotions and salves and all 12 SKUs are infused with a full spectrum CBD oil that is lab tested for quality and accuracy. All products meet established state and federal requirements of no more than 0.3% delta-9-tetrahydrocannabinol and can be sold in all 50 states. The Company will expand the product offerings over the next two quarters in 2021 which will include CBD infused confectionary products and a hydration line to include multi flavored energy drinks.공시 • Dec 17Dog the Bounty Hunter Signs A Two-Year Partnership with CBD Global Sciences to Create and Sell ‘Dog Unleashed CBD’CBD Global Sciences Inc. announced the finalization of an agreement with Dog the Bounty Hunter to launch a CBD product line branded as ‘Dog Unleashed CBD’ which will coincide with his upcoming reality TV docudrama called ‘Dog Unleashed’ in Second Quarter of 2021.Dog the Bounty Hunter and CBD Global Sciences have partnered to create a new CBD brand called ‘Dog Unleashed CBD’ which will roll out First Quarter 2021 with a robust line of CBD products aimed at addressing multiple ailments in the human body using a holistic approach. Initial sales of Dog Unleashed CBD on internet sales platform is set to open by the end of this month. The product launch is timed to coincide with the fourth airing of his reality TV docudrama airing on a subscription-based app and streaming online. While testing the waters on viewership, Dog had over 30,000 new subscribers after just two Instagram postings about the new show. Viewership for the new docudrama is expected to beat all previous records.공시 • Oct 10CBD Global Sciences Launches Aethics Product Line on the First and Most Popular European Ecommerce CBD Market PlatformCBD Global Sciences Inc. announced the launch of its premier CBD product line Aethics on the first and most popular European eCommerce CBD market platform Mellow. The Company will be launching a selection of its most popular Aethics CBD products on the Mellow Store site. The products will be available on the site in the UK, and throughout many other EU countries. Mellow provides a turnkey solution for access to the European CBD marketplace including regulatory compliance and payment and shipping support. Mellows eCommerce CBD marketplace provides customers with the highest quality and reputable CBD brands and products. Products sold through their site are fully vetted by the company and must adhere to the highest level of quality control and industry testing.공시 • Oct 06+ 1 more updateCBD Global Sciences Inc. announced that it has received $0.7744 million in fundingOn September 29, 2020, CBD Global Sciences Inc. (CNSX:CBDN) closed the transaction.공시 • Sep 24CBD Global Sciences Aethics Product Line Receives Vendor Approval From Kroger StoresCBD Global Sciences Inc. announced that the Company has been approved as a CBD vendor with America's grocery retailer. The Kroger Company. The Kroger Company operates, under a variety of brand names, in 2,758 grocery retail locations throughout the U.S. and currently sells CBD products in 1,000+ stores nationwide. The global acceptance of CBD products is helping to broaden the distribution and availability of CBD Global Sciences' "Aethics" product line. The planned expansion by Kroger into additional product lines represents a great opportunity for CBD Global to showcase its Aethics products into approximately 22 states and 1,000+ stores across many of Kroger's retail banners, including Kroger, Dillions, Fry's, Fred Meyer, King Sooper, Pick `n Save, QFC and Smiths.공시 • Aug 07CBD Global Sciences Inc. Auditor Raises 'Going Concern' DoubtCBD Global Sciences Inc. filed its Annual on Jul 30, 2020 for the period ending Dec 31, 2019. In this report its auditor, Davidson & Company, gave an unqualified opinion expressing doubt that the company can continue as a going concern.공시 • Jun 20+ 1 more updateCBD Global Sciences Inc. announced that it has received $0.03 million in fundingOn June 19, 2020, CBD Global Sciences Inc. (CNSX:CBDN) closed the transaction. On the same date, the company has received $15,000 in its second tranche.매출 및 비용 세부 내역CBD Global Sciences가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이CNSX:CBDN 매출, 비용 및 순이익 (USD Millions)날짜매출순이익일반관리비연구개발비31 Mar 220-52031 Dec 210-53030 Sep 210-42030 Jun 210-93031 Mar 210-63031 Dec 200-52030 Sep 20-2-144030 Jun 200-154031 Mar 201-84031 Dec 192-94031 Jul 19000031 Dec 181-330양질의 수익: CBDN 은(는) 현재 수익성이 없습니다.이익 마진 증가: CBDN는 현재 수익성이 없습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: CBDN은 수익성이 없으며 지난 5년 동안 손실이 연평균 4.3% 증가했습니다.성장 가속화: 현재 수익성이 없어 지난 1년간 CBDN의 수익 성장률을 5년 평균과 비교할 수 없습니다.수익 대 산업: CBDN은 수익성이 없어 지난 해 수익 성장률을 Pharmaceuticals 업계(64.6%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: CBDN의 부채가 자산을 초과하여 자본 수익률을 계산하기 어렵습니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YPharmaceuticals-biotech 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2022/10/08 07:50종가2022/07/11 00:00수익2022/03/31연간 수익2021/12/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스CBD Global Sciences Inc.는 0명의 분석가가 다루고 있습니다. 이 중 명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.
공시 • Apr 30Hempacco Co., Inc. (NasdaqCM:HPCO) entered into a non-binding letter of intent to acquire CBD Global Sciences Inc.Hempacco Co., Inc. (NasdaqCM:HPCO) entered into a non-binding letter of intent to acquire CBD Global Sciences Inc. on April 30, 2024. The combined company, to retain the name “Illumination Brands”. The parties have not yet finalized the terms of the potential business combination, a definitive combination agreement has not yet been entered into, and there is no guarantee that a definitive agreement will be entered into, or that the contemplated business combination will ever occur.
Board Change • Apr 27No independent directorsFollowing the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 6 non-independent directors. Director Jeff Hays was the last director to join the board, commencing their role in 2021. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model.
공시 • Apr 27CBD Global Sciences Inc. Announces Change of Chief Financial OfficerCBD Global Sciences Inc. announced that Mr. Alexander McAulay tendered his resignation as Chief Financial Officer (“CFO”) of the Company effective April 14, 2022. The Company also announced that Mr. Glenn Dooley has been appointed as the interim Chief Financial Officer of the Company effective April 14, 2022. Mr. Dooley is also a director and Chief Operating Officer of the Company. He was a co-founder of Strasburg Pharms, LLC, SMBT, LLC and CannaOil Inc., all wholly-owned subsidiaries of Global NV. He is also a co-founder/co-owner, broker and operations manager of MAC5 Mortgage Inc. which he founded with Brad Wyatt in 2006.
공시 • Apr 06CBD Global Sciences Inc., Annual General Meeting, May 12, 2022CBD Global Sciences Inc., Annual General Meeting, May 12, 2022.
공시 • Feb 17CBD Global Sciences, Inc. Announces the Successful Launch of Rap Snacks in the Colorado Market That Exceeded First Week Sales ExpectationsCBD Global Sciences Inc. announced the successful launch of Rap Snacks in the Colorado market that exceeded first week sales expectations. Within the first week of sales to the first few hundred of over 5000 stores in the Colorado and Wyoming markets the team sold through its first order of RAP SNACKS® and has placed additional and larger orders as demand for the tasty snack grows exponentially. Within the first couple of days into its soft launch store owners gobbled up all the inventory forcing a reorder of the product to continue to introduce Colorado and parts of Wyoming to Rap Snacks. Shortly after the launch of the snack product, the Oowee Lemonade made its way into the distribution channel with the same positive response for the new products.
Board Change • Sep 28No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. No highly experienced directors. No independent directors (5 non-independent directors). was the last director to join the board, commencing their role in . The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
공시 • Mar 17Legacy Distribution Group, a Subsidiary of CBD Global Sciences, to Begin Distribution for LIFEAID Beverage Co.(R)CBD Global Sciences Inc., shared that it is adding new brands to its distribution channel. Legacy Distribution Group, "Legacy Distribution" (Denver, CO) is one of the country's first CBD-only Direct Store Delivery (DSD) distributors. CBD Global's Legacy Distribution Group is excited to announce the addition of LIFEAID Beverage Co.(R) to its family of brands. Legacy will be carrying the LIFEAID Hemp line and expects it to be one of the most successful products in their portfolio.
Is New 90 Day High Low • Feb 06New 90-day high: CA$0.34The company is up 15% from its price of CA$0.30 on 06 November 2020. The Canadian market is up 14% over the last 90 days, indicating the company outperformed over that time. However, it underperformed the Pharmaceuticals industry, which is up 70% over the same period.
공시 • Jan 13Ed McCaffrey and CBD Global Sciences Sign A Two-Year Endorsement Agreement with Aethics(TM)CBD Global Sciences Inc. announced the finalization of an agreement with Ed McCaffrey, three-time Superbowl Champion and Pro Bowl Athlete, to endorse the Company's CBD infused sports wellness brand Aethics(TM). Ed McCaffrey, former NFL Athlete, has decided to endorse Aethics(TM), a CBD infused sports wellness product line that includes full spectrum tinctures, topicals, hydration and confectionary products. Ed was extremely pleased to find a CBD infused product line geared towards athletes that focuses on mitigating pain and other ailments for the human body in an all-natural way.
공시 • Jan 09CBD Global Sciences, Inc. Announces to Launch of the New CBD Product Line Dog Unleashed CBDCBD Global Sciences Inc. announced the launch of the new CBD product line “Dog Unleashed CBD”. Dog the Bounty Hunter and CBD Global Sciences have partnered to create a new CBD brand called ‘Dog Unleashed CBD’ which has been rolled out with a robust line of CBD products aimed at addressing multiple ailments in the human body with a holistic approach. Initial sales of Dog Unleashed CBD can be found at www.dogunleashedcbd.com, an internet sales platform. The product launch is timed to coincide with his reality TV docudrama Dog Unleashed, that is airing on a subscription-based app and will be streaming online. The initial product line will offer 12 different SKUs focused on multi-flavored tinctures offered in three different strengths 1000MG, 2000MG and 3500MG. In addition to the tincture products, Dog will offer both lotions and salves and all 12 SKUs are infused with a full spectrum CBD oil that is lab tested for quality and accuracy. All products meet established state and federal requirements of no more than 0.3% delta-9-tetrahydrocannabinol and can be sold in all 50 states. The Company will expand the product offerings over the next two quarters in 2021 which will include CBD infused confectionary products and a hydration line to include multi flavored energy drinks.
공시 • Dec 17Dog the Bounty Hunter Signs A Two-Year Partnership with CBD Global Sciences to Create and Sell ‘Dog Unleashed CBD’CBD Global Sciences Inc. announced the finalization of an agreement with Dog the Bounty Hunter to launch a CBD product line branded as ‘Dog Unleashed CBD’ which will coincide with his upcoming reality TV docudrama called ‘Dog Unleashed’ in Second Quarter of 2021.Dog the Bounty Hunter and CBD Global Sciences have partnered to create a new CBD brand called ‘Dog Unleashed CBD’ which will roll out First Quarter 2021 with a robust line of CBD products aimed at addressing multiple ailments in the human body using a holistic approach. Initial sales of Dog Unleashed CBD on internet sales platform is set to open by the end of this month. The product launch is timed to coincide with the fourth airing of his reality TV docudrama airing on a subscription-based app and streaming online. While testing the waters on viewership, Dog had over 30,000 new subscribers after just two Instagram postings about the new show. Viewership for the new docudrama is expected to beat all previous records.
공시 • Oct 10CBD Global Sciences Launches Aethics Product Line on the First and Most Popular European Ecommerce CBD Market PlatformCBD Global Sciences Inc. announced the launch of its premier CBD product line Aethics on the first and most popular European eCommerce CBD market platform Mellow. The Company will be launching a selection of its most popular Aethics CBD products on the Mellow Store site. The products will be available on the site in the UK, and throughout many other EU countries. Mellow provides a turnkey solution for access to the European CBD marketplace including regulatory compliance and payment and shipping support. Mellows eCommerce CBD marketplace provides customers with the highest quality and reputable CBD brands and products. Products sold through their site are fully vetted by the company and must adhere to the highest level of quality control and industry testing.
공시 • Oct 06+ 1 more updateCBD Global Sciences Inc. announced that it has received $0.7744 million in fundingOn September 29, 2020, CBD Global Sciences Inc. (CNSX:CBDN) closed the transaction.
공시 • Sep 24CBD Global Sciences Aethics Product Line Receives Vendor Approval From Kroger StoresCBD Global Sciences Inc. announced that the Company has been approved as a CBD vendor with America's grocery retailer. The Kroger Company. The Kroger Company operates, under a variety of brand names, in 2,758 grocery retail locations throughout the U.S. and currently sells CBD products in 1,000+ stores nationwide. The global acceptance of CBD products is helping to broaden the distribution and availability of CBD Global Sciences' "Aethics" product line. The planned expansion by Kroger into additional product lines represents a great opportunity for CBD Global to showcase its Aethics products into approximately 22 states and 1,000+ stores across many of Kroger's retail banners, including Kroger, Dillions, Fry's, Fred Meyer, King Sooper, Pick `n Save, QFC and Smiths.
공시 • Aug 07CBD Global Sciences Inc. Auditor Raises 'Going Concern' DoubtCBD Global Sciences Inc. filed its Annual on Jul 30, 2020 for the period ending Dec 31, 2019. In this report its auditor, Davidson & Company, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
공시 • Jun 20+ 1 more updateCBD Global Sciences Inc. announced that it has received $0.03 million in fundingOn June 19, 2020, CBD Global Sciences Inc. (CNSX:CBDN) closed the transaction. On the same date, the company has received $15,000 in its second tranche.